G
Guardant Health
Improving patient health through technology breakthroughs in oncology.
At a glance
- Founded
- 2012
- Headquarters
- Palo Alto, United States
- Listing
- IPO 2018
- Sector
- Biotech & Life Sciences
- Power Law
- Decacorn$10B+ valuation tierThoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning Guardant Health.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- FNFarzad (Zod) Nazem
- FMfrank malek
- OPOsage University Partners
Sequoia
Series B and later16 investors entered at this stage
- HGHeritage Group
OrbiMed- LWLing Wong.
Felicis
Khosla Ventures
Lightspeed Venture Partners
Plug and Play
Pear Ventures
Formation 8
SoftBank
SoftBank Vision Fund
SGH Capital
8VC- SASequoia Amsterdam
Temasek
Signatures Capital
Source: Dealroom Talent Intelligence.
Alumni founders
Former Guardant Health employees who went on to found companies, sorted by Dealroom signal score.
Warren HogarthUnited States
JHJimini HealthEst. 2023
Mark JacobsteinUnited States
Rajan Jethwa Ma MrcsUnited Kingdom
AQAqtualEst. 2018
Diana AbduevaUnited States
XIXilisEst. 2019
Daniel DelubacUnited StatesGlobal footprint
across markets
Patents
175 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Guardant Health was the backer or acquirer, 2021–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
2 deals across Guardant Health's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Guardant Health deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Guardant Health's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Guardant Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Guardant Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.